We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Insulated Transport System Safeguards Transplant Hearts

By HospiMedica International staff writers
Posted on 23 Jan 2019
A new organ transport system protects small adult and pediatric donor hearts on their way to transplant recipients.

The Paragonix Technologies (Braintree, MA, USA) SherpaPak cardiac transport system (CTS) is a single-use storage unit designed to standardize donor heart preservation and transport during triage to the recipient patient. More...
To maintain a cold storage temperature range of 4-8°C, SherpaPak combines an insulated double walled rigid storage canister, non-toxic disposable cold packs, and a cradle to immerse and suspend the heart in a cold storage fluid that provides thermal stability at ambient and extreme temperatures.

Features of the system include an inner organ canister with a volume of four liters, a suspension system that provides both physical and thermal protection to the heart, a real-time preservation temperature sensor, and connectors to cover most aorta sizes, allowing transport of both adult and pediatric hearts. A data logger monitors organ temperature during transport, and a Bluetooth connectivity app monitors, records, and downloads preservation temperature and storage times to handheld devices. The intended organ storage time is up to four hours, but thermal stability has been demonstrated for over 12 hours.

“Our effective product implementation plan, combined with a variety of clinical support tools tailored individually to each transplant center, have resulted in sustained clinical utilization of Paragonix SherpaPak cardiac transport system,” said Bill Edelman, chairman and CEO of Paragonix. “We believe that improving the utilization of donated hearts is critical to patients in end-stage heart failure who are desperate for this precious commodity.”

Approximately 3,500 heart transplants are performed every year in the world, more than half of which occur in the United States. Post-operation survival periods average 15 years.

Related Links:
Paragonix Technologies


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.